(Q33221159)

English

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial (English)

1 reference

Europe PubMed Central

24 July 2017

phase I clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Atencio IA

1

1 reference

Europe PubMed Central

24 July 2017

Grace M

2

1 reference

Europe PubMed Central

24 July 2017

Bordens R

3

1 reference

Europe PubMed Central

24 July 2017

Fritz M

4

1 reference

Europe PubMed Central

24 July 2017

Horowitz JA

5

1 reference

Europe PubMed Central

24 July 2017

Hutchins B

6

1 reference

Europe PubMed Central

24 July 2017

Indelicato S

7

1 reference

Europe PubMed Central

24 July 2017

Jacobs S

8

1 reference

Europe PubMed Central

24 July 2017

Kolz K

9

1 reference

Europe PubMed Central

24 July 2017

Maneval D

10

1 reference

Europe PubMed Central

24 July 2017

Musco ML

11

1 reference

Europe PubMed Central

24 July 2017

Shinoda J

12

1 reference

Europe PubMed Central

24 July 2017

Venook A

13

1 reference

Europe PubMed Central

24 July 2017

Wen S

14

1 reference

Europe PubMed Central

24 July 2017

Warren R

15

1 reference

Europe PubMed Central

24 July 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

24 July 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

24 July 2017

13

1 reference

Europe PubMed Central

24 July 2017

169-181

1 reference

Europe PubMed Central

24 July 2017

2

1 reference

Europe PubMed Central

24 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700870

0 references

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Control of apoptosis by p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Gene therapy progress and prospects: adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Adenoviruses as gene-delivery vehicles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Transductional targeting with recombinant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

A novel method for real time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

21 January 2018

Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Surrogate marker for predicting the virus binding of urogenital cancer cells during adenovirus-based gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700870

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700870

1 reference

Europe PubMed Central

24 July 2017

Dimensions Publication ID

0 references

release_re2voafg3vc3zlbvgiv4n5tdyi

1 reference

https://api.fatcat.wiki/v0/release/re2voafg3vc3zlbvgiv4n5tdyi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33221159&oldid=1835865097"